| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020351 |
| Receipt No. | R000023512 |
| Official scientific title of the study | Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula |
| Date of disclosure of the study information | 2015/12/25 |
| Last modified on | 2016/05/23 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula | |
| Title of the study (Brief title) | Trichloroacetate chemocauterization for pyriform sinus fistula | |
| Region |
|
|
| Condition | ||
| Condition | pyrifirm sinus fistula | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | duration of recurrence-free observation |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | chemocauterization of internal opening of pyriform sinus fistula with 30% trichloroacetate is performed under general anesthesia | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who was suffered from neck abscess caused by pyriform sinus fistula | |||
| Key exclusion criteria | Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible | |||
| Target sample size | 1 | |||
| Research contact person | |
| Name of lead principal investigator | Tomokazu Yoshizaki |
| Organization | Kanazawa University |
| Division name | Otolaryngology-Head and Neck Surgery |
| Address | 13-1 Takaramachi, Kanazawa, Ishikawa |
| TEL | 076-265-2413 |
| tomoy@med.kanazawa-u.ac.jp | |
| Public contact | |
| Name of contact person | Shigeyuki Murono |
| Organization | Kanazawa University |
| Division name | Otolaryngology-Head and Neck Surgery |
| Address | 13-1 Takaramachi, Kanazawa, Ishikawa |
| TEL | 076-265-2413 |
| Homepage URL | |
| murono@med.kanazawa-u.ac.jp | |
| Sponsor | |
| Institute | Kanazawa University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Otolaryngology-Head and Neck Surgery, Kanazawa University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023512 |